首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >LncRNA CR749391 acts as a tumor suppressor to upregulate KLF6 expression via interacting with miR-181a in gastric cancer
【2h】

LncRNA CR749391 acts as a tumor suppressor to upregulate KLF6 expression via interacting with miR-181a in gastric cancer

机译:LncRNA CR749391通过与miR-181a相互作用在胃癌中起抑癌作用以上调KLF6表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Long non-coding RNAs (lncRNAs) are novel regulators for post-transcriptional gene expression, and altered lncRNAs function and expression are associated with tumorigenesis and cancer progression, although the biological functions of most lncRNAs in various cancer types and their underlying regulatory interactions have remained largely elusive. Our previous study identified microRNA (miR)-181a as a regulator of Kruppel-like factor 6 (KLF6). In the present study, a bioinformatical analysis was performed to identify the novel lncRNA as a potential regulator of miR-181a that contains four putative binding sites. Subsequent experiments in gastric cancer (GC) cells demonstrated that interacted with miR-181a to regulate KLF6 expression. First, a direct binding interaction was confirmed using luciferase reporter and RNA immunoprecipitation and pull-down assays. In addition, was observed to be downregulated in GC compared with that of normal gastric cell lines. A functional study also revealed that depletion in normal gastric epithelial cells promoted cell viability, migration and invasion, and conferred resistance to apoptosis, whereas ectopic overexpression had the opposite effect in GC cells and inhibited tumor growth. In addition, was observed to be downregulated in GC compared with that of normal gastric tissues, which was associated with KLF6 but inversely associated with miR-181a levels. Overall, the /miR-181a regulatory interaction and association between and KLF6 may enhance the current understanding of GC pathogenesis, although association with GC prognosis needs further study. The current study could provide a novel approach for lncRNA-mediated targeted GC therapy.
机译:长的非编码RNA(lncRNA)是转录后基因表达的新型调节剂,改变的lncRNA功能和表达与肿瘤发生和癌症进展相关,尽管大多数lncRNA在各种癌症类型中的生物学功能及其潜在的调控相互作用仍然存在在很大程度上难以捉摸。我们之前的研究确定microRNA(miR)-181a是Kruppel样因子6(KLF6)的调节剂。在本研究中,进行了生物信息学分析,以鉴定新的lncRNA作为miR-181a的潜在调控因子,其中包含四个假定的结合位点。随后在胃癌(GC)细胞中进行的实验表明,它与miR-181a相互作用以调节KLF6表达。首先,使用萤光素酶报道分子和RNA免疫沉淀法和下拉法确定了直接结合相互作用。此外,与正常胃细胞系相比,GC中的表达被下调。一项功能研究还显示,正常胃上皮细胞的耗竭促进细胞活力,迁移和侵袭,并赋予其对凋亡的抗性,而异位过表达在GC细胞中具有相反的作用并抑制肿瘤的生长。此外,与正常胃组织相比,GC中的下调被观察到,这与KLF6有关,但与miR-181a水平成反比。总的来说,/ miR-181a与KLF6之间的调控相互作用和关联可能会增强当前对GC发病机理的了解,尽管与GC预后的关联尚需进一步研究。本研究可以为lncRNA介导的靶向GC治疗提供一种新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号